Interrelationship between clinical symptoms expressiveness and brush-biopsy cell count and proteinases and its inhibitors in sputum at smokers and nonsmokers with COPD Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment Year: 2011
Bronchial biopsies composition in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004
Expression of elastolytic proteases in lung parenchyma from COPD compared to normal subjects and healthy smokers Source: Eur Respir J 2004; 24: Suppl. 48, 44s Year: 2004
Association of sputum eosinophils with small airway obstruction in cigarette smokers Source: Eur Respir J 2005; 26: Suppl. 49, 105s Year: 2005
The cellular composition and macrophage phenotypes in induced sputum in smokers and ex-smokers with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 67s Year: 2001
Bronchial biopsies cells count in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006
Gender differences in 5- and 12/15-lipoxygenases products in bronchoalveolar lavage fluid from healthy never-smokers, smoker and COPD patients Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
Airway inflammatory cell compounds in smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 798s Year: 2006
Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
Low sputum MMP-9/TIMP ratio is associated with airway narrowing in smokers with asthma Source: Eur Respir J 2014; 44: 895-904 Year: 2014
Induced sputum microbiome in smoker and non-smoker COPD subjects and its association with lung function in Indian subjects Source: International Congress 2017 – COPD: microbiome composition and the role of antibiotics Year: 2017
Cell spectrum and oxidant/anti-oxidant status of induced sputum in smokers with airway obstruction versus smokers without obstruction and nonsmokers Source: Eur Respir J 2001; 18: Suppl. 33, 92s Year: 2001
Correlation between sputum cytology and lung physiology in asthma and COPD subjects in Indian population Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012
Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004
Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009
Different cytological alterations of bronchial mucosa in 178 smoking and non-smoking patients, suffering from COPD: the importance of endobronchial brushing Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung Year: 2009
Bronchial airway expression of mucin-related, ENaC and chloride channel genes in COPD and non-COPD smokers compared to former and never smokers Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015
Inflammation of airways and results of 6-MWT at smokers with bronchial asthma. Source: International Congress 2017 – Smoking and molecular findings Year: 2017
Biomarker reproducibility study in exhaled breath and induced sputum in nonsmokers, smokers and COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003